Patents by Inventor Paul Martin Gore

Paul Martin Gore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazole compounds acting against allergic, immune and inflammatory conditions
    Patent number: 9156791
    Abstract: The present invention relates to a pyrazole amide derivative, pharmaceutical compositions containing this compound and to its use in therapy.
    Type: Grant
    Filed: October 19, 2011
    Date of Patent: October 13, 2015
    Assignee: Glaxo Group Limited
    Inventors: Anthony William James Cooper, Paul Martin Gore, David House
  • Pyrazole compounds acting against allergic, inflammatory and immune disorders
    Patent number: 9149462
    Abstract: The present invention relates to pyrazole amide derivatives pharmaceutical compositions containing these compounds and to their use in therapy.
    Type: Grant
    Filed: October 19, 2011
    Date of Patent: October 6, 2015
    Assignee: Glaxo Group Limited
    Inventors: Anthony William James Cooper, Paul Martin Gore, David House
  • PYRAZOLE COMPOUNDS ACTING AGAINST ALLERGIC, INFLAMMATORY AND IMMUNE DISORDERS
    Publication number: 20130217658
    Abstract: The present invention relates to pyrazole amide derivatives pharmaceutical compositions containing these compounds and to their use in therapy.
    Type: Application
    Filed: October 19, 2011
    Publication date: August 22, 2013
    Applicant: GLAXO GROUP LIMITED
    Inventors: Anthony William James Cooper, Paul Martin Gore, David House
  • Pyrazole Compounds Acting Against Allergic, Immune and Inflammatory Conditions
    Publication number: 20130203705
    Abstract: The present invention relates to a pyrazole amide derivative, pharmaceutical compositions containing this compound and to its use in therapy.
    Type: Application
    Filed: October 19, 2011
    Publication date: August 8, 2013
    Applicant: Glaxo Group Limited
    Inventors: Anthony William James Cooper, Paul Martin Gore, David House
  • N-pyrazolyl carboxamides as CRAC channel inhibitors
    Patent number: 8399436
    Abstract: The present invention relates to amide compounds, processes for their preparation, pharmaceutical compositions containing these compounds and to their use in the treatment of disorders, conditions or disorders such as allergic disorders, inflammatory disorders and disorders of the immune system.
    Type: Grant
    Filed: April 22, 2010
    Date of Patent: March 19, 2013
    Assignee: Glaxo Group Limited
    Inventors: David George Allen, Diane Mary Coe, Anthony William James Cooper, Paul Martin Gore, David House, Stefan Senger, Steven Leslie Sollis, Sadie Vile, Caroline Wilson
  • N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INIHIBITORS
    Publication number: 20120053150
    Abstract: The present invention relates to amide compounds, processes for their preparation, pharmaceutical compositions containing these compounds and to their use in the treatment of disorders, conditions or disorders such as allergic disorders, inflammatory disorders and disorders of the immune system.
    Type: Application
    Filed: April 22, 2010
    Publication date: March 1, 2012
    Inventors: David George Allen, Diane Mary Coe, Anthony William James Cooper, Paul Martin Gore, David House, Stefan Senger, Steven Leslie Sollis, Sadie Vile, Caroline Wilson
  • PYRAZOLE AND TRIAZOLE CARBOXAMIDES AS CRAC CHANN EL INHIBITORS
    Publication number: 20120035237
    Abstract: The present invention relates to amide compounds, processes for their preparation, intermediates usable in these processes, pharmaceutical compositions containing these compounds and to their use in therapy.
    Type: Application
    Filed: April 22, 2010
    Publication date: February 9, 2012
    Inventors: Diane Mary Coe, Anthony William James Cooper, Paul Martin Gore, David House, Stefan Senger, Sadie Vile
  • SUBSTITUTED QUINOLINE DERIVATIVES AS H1 RECEPTOR ANTAGONISTS
    Publication number: 20110281909
    Abstract: The present invention relates to compounds of formula (I), and salts thereof, processes for their preparation, to compositions containing them and to their use in the treatment of various diseases, such as allergic rhinitis.
    Type: Application
    Filed: August 13, 2008
    Publication date: November 17, 2011
    Applicant: GLAXO GROUP LIMITED
    Inventors: Paul Martin Gore, Ashley Paul Hancock, Simon Teanby Hodgson, Panayiotis Alexandrou Procopiou, Sadie Vile
  • Compounds
    Patent number: 7884114
    Abstract: The present invention relates to a compound which is N-(4-{4-[(6-butyl-8-quinolinyl)oxy]-1-piperidinyl}butyl)ethanesulfonamide and salts thereof, processes for its preparation, to compositions containing it and to its use in the treatment of various diseases, such as allergic rhinitis.
    Type: Grant
    Filed: August 13, 2008
    Date of Patent: February 8, 2011
    Assignee: Glaxo Group Limited
    Inventors: Paul Martin Gore, Ashley Paul Hancock, Simon Teanby Hodgson, Panayiotis Alexandrou Procopiou, Sadie Vile
  • COMPOUNDS
    Publication number: 20100273744
    Abstract: The present invention relates to amide compounds, processes for their preparation, pharmaceutical compositions containing these compounds and to their use in the treatment of disorders, conditions or disorders such as allergic disorders, inflammatory disorders and disorders of the immune system.
    Type: Application
    Filed: April 22, 2010
    Publication date: October 28, 2010
    Inventors: Paul Martin Gore, Steven Leslie Sollis
  • QUINOLINE DERIVATIVES USED TO TREAT INFLAMMATORY AND ALLERGIC DISEASES
    Publication number: 20100222349
    Abstract: The present invention relates to compounds of formula (I) and salts thereof, processes for their preparation, to compositions containing them and to their use in the treatment of various diseases, such as allergic rhinitis.
    Type: Application
    Filed: October 15, 2008
    Publication date: September 2, 2010
    Applicant: Glaxo Group Limited
    Inventors: Paul Martin Gore, Ashley Paul Hancock, Simon Teanby Hodgson, Michael Joachim Kranz, Panayiotis Alexandrou Procopiou, Sadie Vile
  • PHTHALAZINE AND PYRIDO[3,4-D]PYRIDAZINE COMPOUNDS AS H1 RECEPTOR ANTAGONISTS
    Publication number: 20100216799
    Abstract: The present invention relates to compounds of formula (I), and salts thereof, processes for their preparation, to compositions containing them and to their use in the treatment of various diseases, such as allergic rhinitis.
    Type: Application
    Filed: October 10, 2008
    Publication date: August 26, 2010
    Applicant: Glaxo Group Limited
    Inventors: Paul Martin Gore, Brian Edgar Looker, Panayiotis Alexandrou Procopiou, Sadie Vile
  • COMPOUNDS
    Publication number: 20100184770
    Abstract: The present invention relates to a compound of formula (I) and salts thereof, process for preparation thereof, to compositions containing the same and to the use of such a compound in the treatment of various diseases, such as allergic rhinitis.
    Type: Application
    Filed: December 18, 2007
    Publication date: July 22, 2010
    Inventors: Paul Martin Gore, Michael Joachim Kranz, Brian Edgar Looker, Sadie Vile
  • Morpholinyl-urea derivatives for use in the treatment of inflammatory diseases
    Patent number: 7622464
    Abstract: Compounds of formula (I): wherein: R1 represents substituted or unsubstituted heteroaryl; Y represents —(CRnaRnb)n—; Rna and Rnb are each independently hydrogen or C1-6alkyl; n is an integer from 0 to 5; R2 represents unsubstituted or substituted aryl or unsubstituted or substituted heteroaryl; R3 and R4 each independently represent hydrogen or C1-6-alkyl; R7 represents hydrogen or C1-6alkyl; R8 represents hydrogen or C1-6alkyl; and salts and solvates thereof; are CCR3 antagonists and are thus indicated to be useful in therapy.
    Type: Grant
    Filed: March 27, 2003
    Date of Patent: November 24, 2009
    Assignee: Glaxo Group Limited
    Inventors: Rachael Ann Ancliff, Caroline Mary Cook, Colin David Eldred, Paul Martin Gore, Lee Andrew Harrison, Martin Alistair Hayes, Simon Teanby Hodgson, Duncan Bruce Judd, Suzanne Elaine Keeling, Xiao Qing Lewell, Gail Mills, Graeme Michael Robertson, Stephen Swanson, Andrew John Walker, Mark Wilkinson
  • Compounds
    Publication number: 20090270355
    Abstract: The present invention relates to a compound which is N-(4-{4-[(6-butyl-8-quinolinyl)oxy]-1-piperidinyl}butyl)ethanesulfonamide and salts thereof, processes for its preparation, to compositions containing it and to its use in the treatment of various diseases, such as allergic rhinitis.
    Type: Application
    Filed: August 13, 2008
    Publication date: October 29, 2009
    Applicant: Glaxo Group Limited
    Inventors: Paul Martin Gore, Ashley Paul Hancock, Simon Teanby Hodgson, Panayiotis Alexandrou Procopiou, Sadie Vile
  • 2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 Antagonists
    Publication number: 20090105225
    Abstract: The present invention relates to compounds of formula (I), and salts thereof, processes for their preparation, to compositions containing them and to their use in the treatment of various disorders, such as allergic rhinitis.
    Type: Application
    Filed: April 18, 2007
    Publication date: April 23, 2009
    Applicant: GLAXO GROUP LIMITED
    Inventors: Paul Martin Gore, Ashley Paul Hancock, Simon Teanby Hodgson, Leanda Jane Kindon, Panayiotis Alexandrou Procopiou
  • Compounds useful in the treatment of inflammatory diseases
    Patent number: 7157457
    Abstract: There are provided according to the invention, novel compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, X, a, b and Z are as defined in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: January 2, 2007
    Assignee: Glaxo Group Limited
    Inventors: Rachael Anne Ancliff, Caroline Mary Cook, Colin David Eldred, Paul Martin Gore, Lee Andrew Harrison, Simon Teanby Hodgson, Duncan Bruce Judd, Suzanne Elaine Keeling, Xiao Qing Lewell, Graeme Michael Robertson, Stephen Swanson
  • Morpholin-acetamide derivatives for the treatment of inflammatory diseases
    Patent number: 7101882
    Abstract: The present invention relates to novel morpholin-acetamide compounds of formula (I) useful for the treatment of inflammatory diseases. Compounds of formula (I) wherein R1, R2, R3, R4, R5, X, a, b and Z are as defined in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: September 5, 2006
    Assignee: Glaxo Group Limited
    Inventors: Rachael Anne Ancliff, Caroline Mary Cook, Colin David Eldred, Paul Martin Gore, Lee Andrew Harrison, Simon Teanby Hodgson, Duncan Bruce Judd, Suzanne Elaine Keeling, Xiao Qing Lewell, Graeme Michael Robertson, Stephen Swanson
  • Compounds useful in the treatment of inflammatory diseases
    Patent number: 6867192
    Abstract: There are provided according to the invention, novel compounds of formula (I) wherein R1, R2, R3, R4, R5 and R6 are as defined in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
    Type: Grant
    Filed: December 16, 1999
    Date of Patent: March 15, 2005
    Inventors: Duncan Robert Armour, David Brown, Miles Stuart Congreve, Paul Martin Gore, Darren Victor Steven Green, Stuart Holman, Torquil Iain Maclean Jack, Steven Philip Keeling, Andrew McMurtrie Mason, Karen Morriss, Nigel Grahame Ramsden, Peter Ward
  • Compounds useful in the treatment of inflammatory diseases
    Publication number: 20040058907
    Abstract: There are provided according to the invention, novel compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, X a, b, and Z are as defined in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
    Type: Application
    Filed: July 21, 2003
    Publication date: March 25, 2004
    Inventors: Rachael Anne Ancliff, Caroline Mary Cook, Colin David Eldred, Paul Martin Gore, Lee Andrew Harrison, Simon Teanby Hodgson, Duncan Bruce Judd, Suzanne Elaine Keeling, Xiao Qing Lewell, Graeme Michael Robertson, Stephen Swanson